The relationship between hypertension and plasma allantoin, uric acid, xanthine oxidase activity and nitrite, and their predictive capacity in severe preeclampsia

References

• Alasztics B, Kukor Z, Pánczél Z, Valent S. 2012. A praeeclampsia kórélettana a kétlépcsős modell tükrében. Orvosi Hetilap 153:1167–1176.
   PubMedGoogle Scholar
• Bellomo G, Venanzi S, Saronio P, Verdura C, Narducci PL. 2011. Prognostic significance of serum uric acid in women with gestational hypertension. Hypertension 58:704–708.
   PubMed Web of Science ®Google Scholar
• Cnossen JS, de Ruyter-Hanhijarvi H, van der Post JA, Mol BW, Khan KS, ter Riet G. 2006. Accuracy of serum uric acid determination in predicting pre-eclampsia: a systematic review. Acta Obstetrica et Gynecologica Scandinavica 85:519–525.
   PubMed Web of Science ®Google Scholar
• Feig DI, Soletsky B, Johnson RJ. 2008. Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. JAMA 300:924–932.
   PubMed Web of Science ®Google Scholar
• He G, Xu W, Chen Y, Liu X, Xi M. 2013. Abnormal apoptosis of trophoblastic cells is related to the up-regulation of CYP11A gene in placenta of preeclampsia patients. PloS one 8:e59609.
   PubMed Web of Science ®Google Scholar
• Johnson RJ, Kanbay M, Kang DH, Sanchez-Lozada LG, Feig D. 2011. Uric acid: a clinically useful marker to distinguish preeclampsia from gestational hypertension. Hypertension 58:548–549.
   PubMed Web of Science ®Google Scholar
• Kand'ar R, Zakova P. 2008. Allantoin as a marker of oxidative stress in human erythrocytes. Clinical Chemistry and Laboratory Medicine 46:1270–1274.
   PubMed Web of Science ®Google Scholar
• Karabulut AB, Kafkasli A, Burak F, Gozukara EM. 2005. Maternal and fetal plasma adenosine deaminase, xanthine oxidase and malondialdehyde levels in pre-eclampsia. Cell Biochemistry and Function 23:279–283.
   PubMed Web of Science ®Google Scholar
• Koopmans CM, van Pampus MG, Groen H, Aarnoudse JG, van den Berg PP, Mol BW. 2009. Accuracy of serum uric acid as a predictive test for maternal complications in pre-eclampsia: bivariate meta-analysis and decision analysis. European Journal of Obstetrics, Gynecology, and Reproductive Biology 146:8–14.
   PubMed Web of Science ®Google Scholar
• Lamarca B. 2012. Endothelial dysfunction. An important mediator in the pathophysiology of hypertension during pre-eclampsia . Minerva Ginecologica 64:309–320.
   PubMedGoogle Scholar
• Liu X, Lin WM, Yan XH, Chen XH, Hoidal JR, Xu P. 2003. Improved method for measurement of human plasma xanthine oxidoreductase activity. Journal of Chromatography. B, Analytical technologies in the Biomedical and Life Sciences Impact Factor & Information 785:101–114.
   PubMed Web of Science ®Google Scholar
• Loeffler LF, Navas-Acien A, Brady TM, Miller ER 3rd, Fadrowski JJ. 2012. Uric acid level and elevated blood pressure in US adolescents: National Health and Nutrition Examination Survey, 1999–2006. Hypertension 59:811–817.
   PubMed Web of Science ®Google Scholar
• Lundberg JO, Weitzberg E, Gladwin MT. 2008. The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nature Reviews Drug Discovery 7:156–167.
   PubMed Web of Science ®Google Scholar
• Many A, Hubel CA, Roberts JM. 1996. Hyperuricemia and xanthine oxidase in preeclampsia, revisited. American Journal of Obstetrics and Gynecology 174:288–291.
   PubMed Web of Science ®Google Scholar
• Marklund N, Ostman B, Nalmo L, Persson L, Hillered L. 2000. Hypoxanthine, uric acid and allantoin as indicators of in vivo free radical reactions. Description of a HPLC method and human brain microdialysis data . Acta Neurochirurgica (Wien) 142:1135–1141; discussion 1141–1132.
   PubMed Web of Science ®Google Scholar
• Marti R, Murio E, Varela E, Bilbao I, Pascual C, Margarit C, Segura RM. 2004. Xanthine oxidoreductase and preservation injury in human liver transplantation. Transplantation 77:1239–1245.
   PubMed Web of Science ®Google Scholar
• Marti R, Varela E, Pascual C, Segura RM. 2001. Determination of xanthine oxidoreductase forms: influence of reaction conditions. Clinica Chimica Acta 303:117–125.
   PubMed Web of Science ®Google Scholar
• Mustafa R, Ahmed S, Gupta A, Venuto RC. 2012. A comprehensive review of hypertension in pregnancy. Journal of Pregnancy 2012:105918.
   PubMedGoogle Scholar
• Newaz MA, Adeeb NN, Muslim N, Razak TA, Htut NN. 1996. Uric acid, xanthine oxidase and other risk factors of hypertension in normotensive subjects. Clinical and Experimental Hypertension 18:1035–1050.
   PubMed Web of Science ®Google Scholar
• ACOG Committee on Obstetric Practice. 2002. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists. International Journal of Gynaecology and Obstetrics 77:67–75.
   PubMed Web of Science ®Google Scholar
• Redman CW, Beilin LJ, Bonnar J, Wilkinson RH. 1976. Plasma-urate measurements in predicting fetal death in hypertensive pregnancy. Lancet 1:1370–1373.
   PubMed Web of Science ®Google Scholar
• Reister F, Heyl W, Kaufmann P, Rath W. 1999. [Trophoblast invasion in pre-eclampsia]. Zentralblatt fur Gynakologie 121:587–590.
   PubMedGoogle Scholar
• Sagen N, Haram K, Nilsen ST. 1984. Serum urate as a predictor of fetal outcome in severe pre-eclampsia. Acta Obstetrica et Gynecologica Scandinavica 63:71–75.
   PubMed Web of Science ®Google Scholar
• Thangaratinam S, Ismail KM, Sharp S, Coomarasamy A, Khan KS, Tests in Prediction of Pre-eclampsia Severity review group. 2006. Accuracy of serum uric acid in predicting complications of pre-eclampsia: a systematic review. BJOG 113:369–378.
   PubMed Web of Science ®Google Scholar
• Yildirim A, Altinkaynak K, Aksoy H, Sahin YN, Akcay F. 2004. Plasma xanthine oxidase, superoxide dismutase and glutathione peroxidase activities and uric acid levels in severe and mild pre-eclampsia. Cell Biochemistry and Function 22:213–217.
   PubMed Web of Science ®Google Scholar
• Zhang X, Broderick M. 2000. Amperometric detection of nitric oxide. Mod Asp Immunobiol 1:160–165.
   Google Scholar
• Zitnanova I, Korytar P, Aruoma OI, Sustrova M, Garaiova I, Muchova J et al. 2004. Uric acid and allantoin levels in Down syndrome: antioxidant and oxidative stress mechanisms? Clinica Chimica Acta 341:139–146.
   PubMed Web of Science ®Google Scholar